• Explore /
  • Poster
  • / Systemic immune signature of inflammation in metastatic melanoma (MM) patients treated with ipilimumab (IPI) and carboplatin/paclitaxel (CP).

Systemic immune signature of inflammation in metastatic melanoma (MM) patients treated with ipilimumab (IPI) and carboplatin/paclitaxel (CP).

Abstract Poster

Authors

null

Wilson H. Miller

Segal Cancer Center, Jewish General Hospital, Rossy Cancer Network, McGill University, Montreal, QC, Canada

Wilson H. Miller, Rahima Jamal, Eftihia Cocolakis, Pamela Thebault, Jennifer Elisabeth Friedmann, Shirin Kazemi, Jeanne Dionne, Jean-Francois Cailhier, Stephanie Lepage, Karl Belanger, Jean-Pierre M. Ayoub, HB Le, Caroline Lambert, Jida El Hajjar, Leon Van Kempen, Alan Spatz, Rejean Lapointe

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Clinical Trial Registration Number

NCT01676649

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr 185)

DOI

10.1200/JCO.2018.36.5_suppl.185

Abstract #

185

Poster Bd #

J2

Abstract Disclosures

Similar Posters

First Author: Dung Thi Le

First Author: Espen Basmo Ellingsen

First Author: Ines Esteves Domingues Pires Da Silva

First Author: Khashayar Esfahani